Minireviews
Copyright ©The Author(s) 2015.
World J Stem Cells. Apr 26, 2015; 7(3): 649-656
Published online Apr 26, 2015. doi: 10.4252/wjsc.v7.i3.649
Figure 2
Figure 2 Maintenance of pluripotency by leukemia inhibitory factor and small molecules. Green arrows indicate activation, red blunted lines indicate inhibition. The pluripotent cell must self-renew without committing to any specific cell type. This may be achieved by promoting self-renewal and inhibiting commitment by LIF; or by small molecules (in italic) which inhibit (1) signaling through the FGF receptor tyrosine kinase, thus inhibiting commitment; and (2) GSK3, promoting self-renewal. Adapted from[33]. LIF: Leukemia inhibitory factor; FGFr: Fibroblast growth factor receptor-specific tyrosine kinase; GSK3: Glycogen synthase kinase 3; MEK: Mitogen-activated protein kinase.